The total fluorescence intensity of tumor tissues with anti-CCSP-2 scFv-FITC was higher than that of tumor tissues with control scFv-FITC from 15 patients (71%, p = 0.0365, Fig. 4B). This evidence concerns the gene VWA2 and neoplasm.